We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Parker Laboratories

Manufactures medical ultrasound and electromedical contact media, including gels, solid gels, lotions and pads read more Featured Products: More products

Download Mobile App




Parker Labs Partners with Tristel to Deliver Ultrasound Disinfectant for U.S. Market

By MedImaging International staff writers
Posted on 23 Sep 2022
Print article
Image: Tristel DUO is an alcohol- and bleach-free disinfectant that has been shown to be bactericidal, fungicidal, and virucidal (Photo courtesy of Tristel)
Image: Tristel DUO is an alcohol- and bleach-free disinfectant that has been shown to be bactericidal, fungicidal, and virucidal (Photo courtesy of Tristel)

Parker Laboratories Inc. (Fairfield, NJ, USA) has entered a commercial partnership with Tristel plc (Newmarket, UK) to manufacture and distribute the company's disinfectant foams for U.S. markets. Under the exclusive agreement, Parker will manufacture and distribute Tristel DUO, a disinfecting foam approved for the cleaning and disinfection of general medical surfaces, including ultrasound transducers. Tristel DUO is an alcohol- and bleach-free cleaner and disinfectant that has been shown to be bactericidal, fungicidal, and virucidal. It kills Mycobacterium tuberculosis in one minute. Published scientific research concludes that Tristel DUO is successful in inactivating Human papillomavirus (HPV) type 16 and type 18.

Tristel DUO meets the requirements for disinfection of ultrasound transducers used in percutaneous procedures, as detailed in a recently published Intersocietal Position Statement. The position statement advocates the use of cleaning and low-level disinfection with products that are effective against mycobacteria and bloodborne pathogens as safe and sufficient techniques for processing ultrasound transducers used in percutaneous procedures, such as ultrasound-guided peripheral IV insertions. Originally published in the Journal of Ultrasound in Medicine in February 2021, the position statement has since earned the support of 23 healthcare organizations, together representing more than 870,000 physicians, nurses, infection control professionals, and other healthcare professionals.

Tristel DUO is delivered in a novel dosing bottle with two separate compartments; one contains Tristel DUO Part A solution (sodium chlorite) and the other contains Tristel Duo Part B solution (citric acid). Upon pressing the pump, the two solutions mix, and a consistent dose of chlorine dioxide foam is generated. Tristel DUO has been approved by the U.S. Environmental Protection Agency (EPA) for the disinfection of general medical surfaces and equipment. Tristel DUO foam will not damage ultrasound transducers and can be used with any dry wipe, making it a convenient and economical solution for transducer disinfection.

"Tristel's products are used in 35 countries and for millions of disinfection procedures every year," said Neal Buchalter, president of Parker Laboratories. "We're proud of this new partnership with Tristel, as it reflects our continued commitment to improving the safety of any procedure involving ultrasound equipment."

"Tristel DUO is uniquely suited to meet the cleaning and disinfection needs of practitioners who perform ultrasound-guided percutaneous procedures," said Paul Swinney, chief executive of Tristel. "The foam is effective against mycobacteria and bloodborne pathogens, as described in the Intersocietal Position Statement. We're pleased to be partnering with Parker to make this product available to American practitioners, and we expect it will help to resolve some of the challenges they face when processing transducers according to current guidelines."

Related Links:
Parker Laboratories Inc.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Compact C-Arm with FPD
Arcovis DRF-C R21
New
X-Ray Detector
FDR-D-EVO III
Dose Calibration Electrometer
PC Electrometer

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.